Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
V VARIOUS
V10 THERAPEUTIC RADIOPHARMACEUTICALS
V10X OTHER THERAPEUTIC RADIOPHARMACEUTICALS
V10XX Various therapeutic radiopharmaceuticals
V10XX05 Lutetium (177Lu) vipivotide tetraxetan
D12335 Lutetium Lu 177 vipivotide tetraxetan (USAN) <JP/US>
Therapeutic category of drugs in Japan [BR:br08301]
4 Agents affecting cellular function
42 Antineoplastics
429 Miscellaneous
4291 Other Antitumors
D12335 Lutetium Lu 177 vipivotide tetraxetan (USAN)
Target-based classification of drugs [BR:br08310]
Peptidases and inhibitors
Metallo peptidases
Family M28
FOLH1 (PSMA)
D12335 Lutetium Lu 177 vipivotide tetraxetan (USAN) <JP/US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D12335
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D12335
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D12335
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D12335
Pharmacogenomic biomarkers [br08341.html]
Somatic variations in targeted cancer therapies
D12335